THE EFFECT OF PERIOPERATIVE ANALGESIA WITH OMNOPON AND PARECOXIB ON THE ENDOCYTIC ACTIVITY OF MURINE PHAGOCYTES ON THE MODEL OF TUMOR SURGERY

R. I. Sydor, N. M. Khranovska, O. V. Skachkova, L. M. Skivka


DOI: http://dx.doi.org/10.30970/sbi.1002.488

Abstract


We used the model of surgical tumor removal to compare the effect of anesthesia with opioid analgesic omnopon and selective cyclooxygenase-2 inhibitor parecoxib on the endocytic activity of phagocytes of different localization sites. 50 C57/black mice were transplanted with Lewis lung carcinoma in the hind paw pad. After 22 days, the tumor paw was amputated. Analgesics (omnopon 10 mg/kg, parecoxib – 20 mg/kg) were administered 30 min before the operation and once per day for 3 days after the surgery. Assessment of the endocytic activity of phagocytes was performed by FACS analysis before the surgery, at days 1 and 3 after the surgery. It was found that parecoxib analgesia maintained the endocytic activity of blood and spleen phagocytes in the postoperative period. At day 3 after the surgery in parecoxib-treated animals phagocytic activity of splenic granulocytes were 2.2 times higher compared to that in the group receiving opioid analgesia. Phagocytic indices of monocytes in parecoxib-treated mice were also 1.6 and 2.5 times higher for blood and spleen monocytes, respectively. Thus, parecoxib analgesia maintained the activity of blood and spleen phagocytes in mice after the surgical tumor removal at a much higher level as compared with the omnopon analgesia.

Keywords: phagocytic activity, perioperative analgesia, parecoxib, opioid drugs.


Full Text:

PDF

References


1. Bronte V., Pittet M.J. The spleen in local and systemic regulation of immunity. Immunity, 2013; 39(5): 806-18.
https://doi.org/10.1016/j.immuni.2013.10.010
PMid:24238338 PMCid:PMC3912742

2. George B.S., Richard M.K., Kirk J.M. et. al. Endogenous Morphine/Nitric Oxide-Coupled Regulation of Cellular Physiology and Gene Expression: Implications for Cancer Biology. Semin. Cancer. Biol, 2008; 8(3): 199-210.
https://doi.org/10.1016/j.semcancer.2007.12.003
PMid:18203618 PMCid:PMC2432462

3. Harris R.E. Cyclooxygenase-2 blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology, 2009; 17: 55-67.
https://doi.org/10.1007/s10787-009-8049-8
PMid:19340409

4. Kaye A., Patel N., Bueno F. et al. Effect of Opiates, Anesthetic Techniques, and Other Perioperative Factors on Surgical Cancer Patients. The Ochsner Journal, 2014; 14(8): 216-228.

5. Kimura F., Shimizu H., Yoshidome H. Immunosuppression following surgical and traumatic injury. Surg. Today, 2010; 40(9): 793-808.
https://doi.org/10.1007/s00595-010-4323-z
PMid:20740341

6. Kundu J.K., Surh Y.J. Inflammation: gearing the journey to cancer. Mutat. Res, 2008; 659(1-2): 15-30.
https://doi.org/10.1016/j.mrrev.2008.03.002
PMid:18485806

7. Maskrey B.H., Megson I.L., Whitfield P.D. et. al. Mechanisms of Resolution of Inflammation a Focus on Cardiovascular Disease. Arterioscler. Thromb. Vasc. Biol, 2011; 31: 1001-1006.
https://doi.org/10.1161/ATVBAHA.110.213850
PMid:21508346

8. Meserve J.M., Kaye A.D., Prabhakar A. et. al. The Role of Analgesics in Cancer Propagation. Best. Pract. Res. Clin. Anaesthesiol, 2014; 28(2): 139-51.
https://doi.org/10.1016/j.bpa.2014.04.004
PMid:24993435

9. Shirzad H., Shahrani M., Rafieian-Kopaei M. Comparison of morphine and tramadol effects on phagocytic activity of mice peritoneal phagocytes in vivo. Int. Immunopharmacol, 2009; 9(7-8): 968-70.
https://doi.org/10.1016/j.intimp.2009.04.002
PMid:19361579

10. Soehnlein O., Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol, 2010; 10(6): 427-39.
https://doi.org/10.1038/nri2779
PMid:20498669

11. Tanja C. The fundamental role of mechanical properties in the progression of cancer disease and inflammation. Reports on Progress in Physics, 2014; 77(7): 121-126.
https://doi.org/10.1088/0034-4885/77/7/076602
PMid:25006689

12. Wu Y., Zhou B.P. Inflammation: a driving force speeds cancer metastasis. Cell Cycle, 2009; 8(20): 3267-3273.
https://doi.org/10.4161/cc.8.20.9699
PMid:19770594 PMCid:PMC3702728

13. Yiannakopoulou E. Targeting epigenetic mechanisms and microRNAs by aspirin and other non-steroidal anti-inflammatory agents - implications for cancer treatment and chemoprevention. Cell Oncol. (Dordr), 2014; 37(3):167-78.
https://doi.org/10.1007/s13402-014-0175-7
PMid:24996792


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Studia biologica